1-16 of 16
Wenge Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3486: Synergistic effect of quinacrine in combination with decitabine for the treatment of acute myeloid leukemia cells in vitro: implication for treatment of AML in the elderly

Wenge Wang, David T. Dicker, David F. Claxton, Hong-Gang Wang, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3486.
DOI: https://doi.org/10.1158/1538-7445.AM2015-3486
Published: 01 August 2015
View article
Journal Articles

Abstract 2188: A screen to identify novel p53 family member activity-restoring compounds with a focus on p73.

Antonius P. van den Heuvel, Wenge Wang, Levy Kopelovich, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2188.
DOI: https://doi.org/10.1158/1538-7445.AM2013-2188
Published: 15 April 2013
View article
Journal Articles

Abstract 674: Novel combinatorial quinacrine cancer therapies for advanced colon cancer

Jean-Nicolas Gallant, Wenge Wang, Nathan G. Dolloff, Joshua E. Allen, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 674.
DOI: https://doi.org/10.1158/1538-7445.AM2011-674
Published: 15 April 2011
View article
Journal Articles

The Myc–miR-17∼92 Axis Blunts TGFβ Signaling and Production of Multiple TGFβ-Dependent Antiangiogenic Factors

Michael Dews, Jamie L. Fox, Stacy Hultine, Prema Sundaram, Wenge Wang, Yingqiu Y. Liu, Emma Furth, Gregory H. Enders, Wafik El-Deiry, Janell M. Schelter, Michele A. Cleary, Andrei Thomas-Tikhonenko
Journal: Cancer Research
Cancer Res (2010) 70 (20): 8233–8246.
DOI: https://doi.org/10.1158/0008-5472.CAN-10-2412
Published: 13 October 2010
View article
PDF
Journal Articles

Abstract 680: Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL via up-regulating DR5 and eradicating MCL-1

Wenge Wang, Sharyn I. Katz, Junaid Abdulghani, David Dicker, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 680.
DOI: https://doi.org/10.1158/1538-7445.AM10-680
Published: 15 April 2010
View article
Journal Articles

Abstract #4004: TRAIL and Sorafenib combination therapy leads to regression of TRAIL resistant tumors in a xenograft model of human non-small cell lung cancer

Sharyn Katz, LanLan Zhou, Wenge Wang, Patrick Mayes, Charles Smith, Wafik El-Deiry
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4004.
Published: 01 May 2009
View article
Journal Articles

Abstract #4471: Prediction of pro-apoptotic anti-cancer therapeutic response by visualization of death receptors and specific markers of apoptosis

Lanlan Zhou, David Dicker, Wenge Wang, Wafik El-Deiry
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4471.
Published: 01 May 2009
View article
Journal Articles

Abstract #598: p53 and p73 transactivate the proapoptotic early growth response factor EGR2, and its expression is induced by small molecules that restore p53 signaling in tumor cells

Wenge Wang, Wafik El-Deiry
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 598.
Published: 01 May 2009
View article
Journal Articles

Prediction of proapoptotic anticancer therapeutic response by optical imaging of death inducing ligand-receptor interaction

Lanlan Zhou, David Dicker, Wenge Wang, Wafik El-Deiry
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3174.
Published: 01 May 2008
View article
Journal Articles

DR5 Receptor Mediates Anoikis in Human Colorectal Carcinoma Cell Lines

Luciana M. Laguinge, Raed N. Samara, Wenge Wang, Wafik S. El-Deiry, Georgia Corner, Leonard Augenlicht, Lopa Mishra, J. Milburn Jessup
Journal: Cancer Research
Cancer Res (2008) 68 (3): 909–917.
DOI: https://doi.org/10.1158/0008-5472.CAN-06-1806
Published: 01 February 2008
View article
PDF
Includes: Supplementary data
Journal Articles

DNA-intercalating drugs activate p53 transcriptional responses without evidence of DNA-damage signaling

Wenge Wang, Wafik El-Deiry
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2541.
Published: 01 May 2007
View article
Journal Articles

RbBP5 regulates TRAIL and DNA-damaging agent-induced apoptosis in tumor cells

Wenge Wang, Seok-Hyun Kim, David T. Dicker, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 179.
Published: 15 April 2006
View article
Journal Articles

CARPs negatively regulate levels of phosphorylated p53

Wen-Sheng Yang, Laura Rozan, Wenge Wang, Elizabeth Matthew, David T. Dicker, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 787.
Published: 15 April 2006
View article
Journal Articles

CP-31398 induction of death receptor 5 by blockade of protein degradation sensitizes tumor cells to TRAIL

Wenge Wang, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 411–412.
Published: 01 May 2005
View article
Journal Articles

Bioluminescent imaging of p53 activity and screening for potent chemicals that rescue or enhance transcriptional activity of p53 and its family members in tumor cells.

Wenge Wang, Yanping Li, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 700.
Published: 01 April 2004
View article
Journal Articles

Bnip3L is induced by p53 under hypoxia and its knockdown promotes tumor growth

Peiwen Fei, Wenge Wang, Wafik S. El-Deiry
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1114.
Published: 01 April 2004
View article